{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:08:51Z","timestamp":1795057731208,"version":"4.10.2"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7937","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,11,24]]},"DOI":"10.1038\/s41586-022-05432-3","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T12:05:04Z","timestamp":1668600304000},"page":"818-826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":367,"title":["T cells specific for \u03b1-myosin drive immunotherapy-related myocarditis"],"prefix":"10.1038","volume":"611","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-8798","authenticated-orcid":false,"given":"Margaret L.","family":"Axelrod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter C.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elles M.","family":"Screever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0821-6290","authenticated-orcid":false,"given":"Juan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Grace","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Tannous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-5019","authenticated-orcid":false,"given":"Ayaka","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandie C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-9481","authenticated-orcid":false,"given":"Shaoyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Amancherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-7198","authenticated-orcid":false,"given":"Warren","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2043-0150","authenticated-orcid":false,"given":"Jordan J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer C.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Opalenik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail L.","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-3396","authenticated-orcid":false,"given":"Jeffrey C.","family":"Rathmell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-9154","authenticated-orcid":false,"given":"P. Brent","family":"Ferrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7623-3383","authenticated-orcid":false,"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mallal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-773X","authenticated-orcid":false,"given":"Douglas B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid J.","family":"Moslehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-5974","authenticated-orcid":false,"given":"Justin M.","family":"Balko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"5432_CR1","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","volume":"4","author":"DY Wang","year":"2018","unstructured":"Wang, D. Y. et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol. 4, 1721\u20131728 (2018).","journal-title":"JAMA Oncol."},{"key":"5432_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/2159-8290.CD-20-0856","volume":"11","author":"SC Wei","year":"2020","unstructured":"Wei, S. C. et al. A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention. Cancer Discov. 11, 614\u2013639 (2020).","journal-title":"Cancer Discov."},{"key":"5432_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1172\/JCI44583","volume":"121","author":"H Lv","year":"2011","unstructured":"Lv, H. et al. Impaired thymic tolerance to \u03b1-myosin directs autoimmunity to the heart in mice and humans. J. Clin. Invest. 121, 1561\u20131573 (2011).","journal-title":"J. Clin. Invest."},{"key":"5432_CR4","doi-asserted-by":"publisher","first-page":"e0218858","DOI":"10.1371\/journal.pone.0218858","volume":"14","author":"ISM Gabrielsen","year":"2019","unstructured":"Gabrielsen, I. S. M. et al. Transcriptomes of antigen presenting cells in human thymus. PLoS ONE 14, e0218858 (2019).","journal-title":"PLoS ONE"},{"key":"5432_CR5","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson, D. B. et al. Fulminant myocarditis with combination immune checkpoint blockade. N. Engl. J. Med. 375, 1749\u20131755 (2016).","journal-title":"N. Engl. J. Med."},{"key":"5432_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/cvr\/cvz026","volume":"115","author":"J-RR Hu","year":"2019","unstructured":"Hu, J.-R. R. et al. Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc. Res. 115, 854\u2013868 (2019).","journal-title":"Cardiovasc. Res."},{"key":"5432_CR7","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"JE Salem","year":"2018","unstructured":"Salem, J. E. et al. Spectrum of cardiovascular toxicities of immune checkpoint inhibitors: a pharmacovigilance study. Lancet Oncol. 19, 1579\u20131589 (2018).","journal-title":"Lancet Oncol."},{"key":"5432_CR8","doi-asserted-by":"publisher","unstructured":"Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L. & Kitsis, R. N. Immune checkpoint inhibitor\u2013associated myocarditis: manifestations and mechanisms. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI145186 (2021).","DOI":"10.1172\/JCI145186"},{"key":"5432_CR9","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1001\/jamaoncol.2019.3113","volume":"5","author":"Y Zamami","year":"2019","unstructured":"Zamami, Y. et al. Factors associated with immune checkpoint inhibitor-related myocarditis. JAMA Oncol. 5, 1635\u20131637 (2019).","journal-title":"JAMA Oncol."},{"key":"5432_CR10","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMc1901677","volume":"380","author":"J-E Salem","year":"2019","unstructured":"Salem, J.-E. et al. Abatacept for severe immune checkpoint inhibitor-associated myocarditis. N. Engl. J. Med. 380, 2377\u20132379 (2019).","journal-title":"N. Engl. J. Med."},{"key":"5432_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4049\/jimmunol.2000330","volume":"205","author":"X Yang","year":"2020","unstructured":"Yang, X., Bam, M., Becker, W., Nagarkatti, P. S. & Nagarkatti, M. Long noncoding RNA AW112010 promotes the differentiation of inflammatory T cells by suppressing IL-10 expression through histone demethylation. J. Immunol. 205, 987\u2013993 (2020).","journal-title":"J. Immunol."},{"key":"5432_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-018-0794-7","volume":"564","author":"R Jackson","year":"2018","unstructured":"Jackson, R. et al. The translation of non-canonical open reading frames controls mucosal immunity. Nature. 564, 434\u2013438 (2018).","journal-title":"Nature."},{"key":"5432_CR13","doi-asserted-by":"publisher","unstructured":"Adamo, L. et al. Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.134700 (2020).","DOI":"10.1172\/jci.insight.134700"},{"key":"5432_CR14","doi-asserted-by":"publisher","unstructured":"B\u00f6nner, F., Borg, N., Burghoff, S. & Schrader, J. Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0034730 (2012).","DOI":"10.1371\/journal.pone.0034730"},{"key":"5432_CR15","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.119.041694","volume":"140","author":"E Martini","year":"2019","unstructured":"Martini, E. et al. Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation. Circulation. 140, 2089\u20132107 (2019).","journal-title":"Circulation."},{"key":"5432_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1084\/jem.20040779","volume":"200","author":"O Li","year":"2004","unstructured":"Li, O., Zheng, P. & Liu, Y. CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host. J. Exp. Med. 200, 1083\u20131089 (2004).","journal-title":"J. Exp. Med."},{"key":"5432_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/eji.1830240336","volume":"24","author":"M Hubbe","year":"1994","unstructured":"Hubbe, M. & Altevogt, P. Heat-stable antigen\/CD24 on mouse T lymphocytes: evidence for a costimulatory function. Eur. J. Immunol. 24, 731\u2013737 (1994).","journal-title":"Eur. J. Immunol."},{"key":"5432_CR18","doi-asserted-by":"publisher","unstructured":"Szabo P. A., Miron M. & Farber D. L. Location, location, location: tissue resident memory T cells in mice and humans. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aas9673 (2019).","DOI":"10.1126\/sciimmunol.aas9673"},{"key":"5432_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41590-022-01273-4","volume":"23","author":"R Fonseca","year":"2022","unstructured":"Fonseca, R. et al. Runx3 drives a CD8+ T cell tissue residency program that is absent in CD4+ T cells. Nat. Immunol. 23, 1236\u20131245 (2022).","journal-title":"Nat. Immunol."},{"key":"5432_CR20","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.119.044703","volume":"141","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint inhibitor-associated myocarditis. Circulation 141, 2031\u20132034 (2020).","journal-title":"Circulation"},{"key":"5432_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","volume":"335","author":"AE Coutinho","year":"2011","unstructured":"Coutinho, A. E. & Chapman, K. E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol. 335, 2\u201313 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"5432_CR22","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1093\/nar\/gkac190","volume":"1","author":"JM Heather","year":"2022","unstructured":"Heather, J. M. et al. Stitchr: stitching coding TCR nucleotide sequences from V\/J\/CDR3 information. Nucleic Acids Res. 1, e68 (2022).","journal-title":"Nucleic Acids Res."},{"key":"5432_CR23","doi-asserted-by":"publisher","first-page":"17608","DOI":"10.18632\/oncotarget.24807","volume":"9","author":"S Rosskopf","year":"2018","unstructured":"Rosskopf, S. et al. A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies. Oncotarget 9, 17608\u201317619 (2018).","journal-title":"Oncotarget"},{"key":"5432_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jim.2016.01.007","volume":"430","author":"S Jutz","year":"2016","unstructured":"Jutz, S. et al. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: simultaneous measurement of NF-\u03baB, NFAT and AP-1. J. Immunol. Methods. 430, 10\u201320 (2016).","journal-title":"J. Immunol. Methods."},{"key":"5432_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.aav3487","volume":"366","author":"C Gil-Cruz","year":"2019","unstructured":"Gil-Cruz, C. et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science 366, 881\u2013886 (2019).","journal-title":"Science"},{"key":"5432_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cellimm.2011.08.013","volume":"271","author":"C Massilamany","year":"2011","unstructured":"Massilamany, C., Gangaplara, A., Steffen, D. & Reddy, J. Identification of novel mimicry epitopes for cardiac myosin heavy chain-\u03b1 that induce autoimmune myocarditis in A\/J mice. Cell Immunol. 271, 438\u2013449 (2011).","journal-title":"Cell Immunol."},{"key":"5432_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s43018-022-00335-8","volume":"3","author":"SL Meier","year":"2022","unstructured":"Meier, S. L., Satpathy, A. T. & Wells, D. K. Bystander T cells in cancer immunology and therapy. Nat. Cancer 3, 143\u2013155 (2022).","journal-title":"Nat. Cancer"},{"key":"5432_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12980-2","volume":"10","author":"NJ Maurice","year":"2019","unstructured":"Maurice, N. J., McElrath, M. J., Andersen-Nissen, E., Frahm, N. & Prlic, M. CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells. Nat. Commun. 10, 1\u201315 (2019).","journal-title":"Nat. Commun."},{"key":"5432_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575\u2013579 (2018).","journal-title":"Nature"},{"key":"5432_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4049\/jimmunol.2000937","volume":"206","author":"NJ Maurice","year":"2021","unstructured":"Maurice, N. J., Taber, A. K. & Prlic, M. The ugly duckling turned to swan: a change in perception of bystander-activated memory CD8 T Cells. J. Immunol. 206, 455\u2013462 (2021).","journal-title":"J. Immunol."},{"key":"5432_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","volume":"25","author":"W Scheper","year":"2019","unstructured":"Scheper, W. et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89\u201394 (2019).","journal-title":"Nat. Med."},{"key":"5432_CR32","first-page":"18.19.1","volume":"2016","author":"S Paul","year":"2016","unstructured":"Paul, S., Sidney, J., Sette, A. & Peters, B. TepiTool: a pipeline for computational prediction of T cell epitope candidates. Curr. Protoc. Immunol. 2016, 18.19.1\u201318.19.24 (2016).","journal-title":"Curr. Protoc. Immunol."},{"key":"5432_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/351290a0","volume":"351","author":"K Falk","year":"1991","unstructured":"Falk, K., R\u00f6tzschke, O., Stevanovi\u0107, S., Jung, G. & Rammensee, H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290\u2013296 (1991).","journal-title":"Nature"},{"key":"5432_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cell.2020.06.001","volume":"182","author":"AM Luoma","year":"2020","unstructured":"Luoma, A. M. et al. Molecular pathways of colon inflammation induced by cancer immunotherapy. Cell 182, 655\u2013671.e22 (2020).","journal-title":"Cell"},{"key":"5432_CR35","doi-asserted-by":"publisher","first-page":"e120360","DOI":"10.1172\/jci.insight.120360","volume":"3","author":"DB Johnson","year":"2018","unstructured":"Johnson, D. B. et al. Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3\/FCRL6 engagement. JCI Insight 3, e120360 (2018).","journal-title":"JCI Insight"},{"key":"5432_CR36","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-18-4083","volume":"25","author":"C Ji","year":"2019","unstructured":"Ji, C. et al. Myocarditis in cynomolgus monkeys following treatment with immune checkpoint inhibitors. Clin. Cancer Res. 25, 4735\u20134748 (2019).","journal-title":"Clin. Cancer Res."},{"key":"5432_CR37","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","volume":"72","author":"SR Woo","year":"2012","unstructured":"Woo, S. R. et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res. 72, 917\u2013927 (2012).","journal-title":"Cancer Res."},{"key":"5432_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1084\/jem.20100466","volume":"208","author":"T Okazaki","year":"2011","unstructured":"Okazaki, T. et al. PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice. J. Exp. Med. 208, 395\u2013407 (2011).","journal-title":"J. Exp. Med."},{"key":"5432_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aao4572","volume":"359","author":"D Chowell","year":"2018","unstructured":"Chowell, D. et al. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science 359, 582\u2013587 (2018).","journal-title":"Science"},{"key":"5432_CR40","doi-asserted-by":"publisher","unstructured":"Naranbhai, V. et al. HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study. Lancet Oncol. https:\/\/doi.org\/10.1016\/S1470-2045(21)00582-9 (2022).","DOI":"10.1016\/S1470-2045(21)00582-9"},{"key":"5432_CR41","doi-asserted-by":"publisher","unstructured":"Correale, P. et al. HLA expression correlates to the risk of immune checkpoint inhibitor-induced pneumonitis. Cells https:\/\/doi.org\/10.3390\/cells9091964 (2020).","DOI":"10.3390\/cells9091964"},{"key":"5432_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.2018.11.009","volume":"107","author":"O Hasan Ali","year":"2019","unstructured":"Hasan Ali, O. et al. Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. Eur. J. Cancer 107, 8\u201314 (2019).","journal-title":"Eur. J. Cancer"},{"key":"5432_CR43","doi-asserted-by":"publisher","unstructured":"McCulloch, J. A. et al. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-022-01698-2 (2022).","DOI":"10.1038\/s41591-022-01698-2"},{"key":"5432_CR44","doi-asserted-by":"publisher","unstructured":"Andrews, M. C. et al. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-021-01406-6 (2021).","DOI":"10.1038\/s41591-021-01406-6"},{"key":"5432_CR45","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3389\/fimmu.2018.02714","volume":"9","author":"K Van der Borght","year":"2018","unstructured":"Van der Borght, K. et al. Myocarditis elicits dendritic cell and monocyte infiltration in the heart and self-antigen presentation by conventional type 2 dendritic cells. Front. Immunol. 9, 2714 (2018).","journal-title":"Front. Immunol."},{"key":"5432_CR46","doi-asserted-by":"publisher","unstructured":"Rieckmann, M. et al. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci123859 (2019).","DOI":"10.1172\/jci123859"},{"key":"5432_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/cvr\/cvt246","volume":"101","author":"JH Lee","year":"2014","unstructured":"Lee, J. H. et al. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis. Cardiovasc. Res. 101, 203\u2013210 (2014).","journal-title":"Cardiovasc. Res."},{"key":"5432_CR48","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/ijms22020794","volume":"22","author":"K Tajiri","year":"2021","unstructured":"Tajiri, K. et al. A new mouse model of chronic myocarditis induced by recombinant Bacille Calmette\u2013Gu\u00e8rin expressing a T-cell epitope of cardiac myosin heavy chain-\u03b1. Int. J. Mol. Sci. 22, 794 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"5432_CR49","doi-asserted-by":"publisher","unstructured":"Hua, X. et al. Single-cell RNA sequencing to dissect the immunological network of autoimmune myocarditis. Circulation https:\/\/doi.org\/10.1161\/circulationaha.119.043545 (2020).","DOI":"10.1161\/circulationaha.119.043545"},{"key":"5432_CR50","doi-asserted-by":"crossref","unstructured":"Taylor, J. A. et al. A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8. J. Immunol. 172, 2651\u20132658 (2004).","DOI":"10.4049\/jimmunol.172.4.2651"},{"key":"5432_CR51","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","volume":"68","author":"P Mombaerts","year":"1992","unstructured":"Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869\u2013877 (1992).","journal-title":"Cell"},{"key":"5432_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495\u2013502 (2015).","journal-title":"Nat. Biotechnol."},{"key":"5432_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"5432_CR54","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell. 177, 1888\u20131902.e21 (2019).","journal-title":"Cell."},{"key":"5432_CR55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2006.05.042","volume":"126","author":"Y Wu","year":"2006","unstructured":"Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 126, 375\u2013387 (2006).","journal-title":"Cell."},{"key":"5432_CR56","doi-asserted-by":"publisher","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. https:\/\/doi.org\/10.1126\/scisignal.2004088 (2013).","DOI":"10.1126\/scisignal.2004088"},{"key":"5432_CR57","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"5432_CR58","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1046\/j.1365-2184.2003.00276.x","volume":"36","author":"HM Oh","year":"2003","unstructured":"Oh, H. M. et al. An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. Cell Prolif. 36, 191\u2013197 (2003).","journal-title":"Cell Prolif."},{"key":"5432_CR59","doi-asserted-by":"publisher","first-page":"12715","DOI":"10.1128\/JVI.02199-14","volume":"88","author":"M Granato","year":"2014","unstructured":"Granato, M. et al. Epstein\u2013Barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication. J. Virol. 88, 12715 (2014).","journal-title":"J. Virol."},{"key":"5432_CR60","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/nprot.2014.064","volume":"9","author":"M W\u00f6lfl","year":"2014","unstructured":"W\u00f6lfl, M. & Greenberg, P. D. Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells. Nat. Protoc. 9, 950\u2013966 (2014).","journal-title":"Nat. Protoc."},{"key":"5432_CR61","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","volume":"597","author":"CS Eberhardt","year":"2021","unstructured":"Eberhardt, C. S. et al. Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer. Nature 597, 279\u2013284 (2021).","journal-title":"Nature"},{"key":"5432_CR62","unstructured":"Oksanen, J. et al. vegan: Community Ecology Package. R package version 2.5-7 (2020)."},{"key":"5432_CR63","doi-asserted-by":"publisher","unstructured":"Nazarov, V., immunarch.bot, Rumynskiy, E. immunomind\/immunarch: 0.6.5: Basic single-cell support. Zenodo https:\/\/doi.org\/10.5281\/zenodo.3893991 (2020).","DOI":"10.5281\/zenodo.3893991"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05432-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05432-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05432-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:32:12Z","timestamp":1669901532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05432-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":63,"journal-issue":{"issue":"7937","published-print":{"date-parts":[[2022,11,24]]}},"alternative-id":["5432"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05432-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1315661\/v1","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.742413148.793596758","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L.A. is listed as a co-inventor on a provisional patent application for methods to predict therapeutic outcomes using blood-based gene expression patterns, which is owned by Vanderbilt University Medical Center, and is currently unlicensed. S.C.W. is currently an employee of, and has ownership interest in, Spotlight Therapeutics. S.C.W. has received personal fees from BioEntre and AlphaSights. S.C.W. is an inventor on a patent related to a genetic mouse model of immune checkpoint blockade induced immune-related adverse events (PCT\/US2019\/050551) pending to the Board of Regents, The University of Texas System and patent applications submitted by Spotlight Therapeutics related to in vivo gene editing. K.A. serves on the Data Safety Monitoring Board for ACI Clinical. J.C.R. is a founder, scientific advisory board member and stockholder of Sitryx Therapeutics, a scientific advisory board member and stockholder of Caribou Biosciences, a member of the scientific advisory board of Nirogy Therapeutics, has consulted for Merck, Pfizer and Mitobridge within the past 3\u2009years, and has received research support from Incyte, Calithera Biosciences and Tempest Therapeutics. P.B.F. receives research support from Incyte. D.B.J. has served on advisory boards or as a consultant for BMS, Catalyst Biopharma, Iovance, Jansen, Mallinckrodt, Merck, Mosaic ImmunoEngineering, Novartis, Oncosec, Pfizer and Targovax, has received research funding from BMS and Incyte, and has patents pending for use of MHC-II as a biomarker for ICI response, and abatacept as treatment for irAEs. J.P.A. reports personal fees from Achelois, Adaptive Biotechnologies, Apricity Health, BioAtla, Candel Therapeutics, Codiak BioSciences, Dragonfly Therapeutics, Earli, Enable Medicine, Hummingbird, ImaginAb, Jounce Therapeutics, Lava Therapeutics, Lytix Biopharma, Marker Therapeutics, PBM Capital, Phenomic AI, BioNTech, Polaris Pharma, Time Bioventures, Trained Therapeutics, Two Bear Capital, and Venn Biosciences outside the submitted work. In addition, J.P.A. has a patent for a genetic mouse model of immune-checkpoint-blockade-induced irAEs pending to The University of Texas MD Anderson Cancer Center and has received royalties from intellectual property licensed to BMS and Merck. J.J.M. has served on advisory boards for Bristol Myers Squibb, Takeda, Audentes, Deciphera, Janssen, Immuno-Core, Boston Biomedical, Amgen, Myovant, Kurome Therapeutics, Star Therapeutics, ProtinQure, Pharmacyclics, Pfizer, Mallinckrodt Pharmaceuticals, Silverback Therapeutics, Cytokinetics, and AstraZeneca. J.M.B. receives research support from Genentech\/Roche, and Incyte, and is an inventor on provisional patents regarding immunotherapy targets and biomarkers in cancer. No disclosures are reported by the other authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}